Literature DB >> 7031084

Preparation of polyvalent viral immunofluorescent intracellular antigens and use in human serosurveys.

K M Johnson, L H Elliott, D L Heymann.   

Abstract

A method is described for preparation of polyvalent antigens for use in rapid screening for immunofluorescent antibodies to Lassa, Marburg, and Ebola viruses. The technique uses mixtures of specifically infected Vero cells placed on Teflon-templated microscopy slides. It was found to be as sensitive as the use of monovalent antigens for detection and quantitation of antibodies to these highly hazardous human pathogens.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7031084      PMCID： PMC273981          DOI： 10.1128/jcm.14.5.527-529.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  6 in total

1.  Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections.

Authors:  H Wulff; K M Johnson
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

2.  Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations--clinical notes.

Authors:  D I Simpson; E M Knight; G Courtois; M C Williams; M P Weinbren; J W Kibukamusoke
Journal:  East Afr Med J       Date:  1967-02

3.  Rift Valley fever affecting humans in South Africa: a clinicopathological study.

Authors:  D J van Velden; J D Meyer; J Olivier; J H Gear; B McIntosh
Journal:  S Afr Med J       Date:  1977-06-11

4.  Indirect immunofluorescence for the diagnosis of Lassa fever infection.

Authors:  H Wulff; J V Lange
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

5.  Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978.

Authors:  D L Heymann; J S Weisfeld; P A Webb; K M Johnson; T Cairns; H Berquist
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

6.  [Antibodies against the Marburg virus among human populations in the southeastern Central African Republic].

Authors:  J F Saluzzo; J P Gonzalez; A J Georges; K M Johnson
Journal:  C R Seances Acad Sci III       Date:  1981-01-05
  6 in total
  12 in total

Review 1.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

2.  Rapid diagnosis of human Crimean-Congo hemorrhagic fever and detection of the virus in naturally infected ticks.

Authors:  J F Saluzzo; B Le Guenno
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

3.  Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

4.  Inactivation of Lassa, Marburg, and Ebola viruses by gamma irradiation.

Authors:  L H Elliott; J B McCormick; K M Johnson
Journal:  J Clin Microbiol       Date:  1982-10       Impact factor: 5.948

5.  Enzyme-linked immunosorbent assays for detection of antibodies to Ebola and Marburg viruses using recombinant nucleoproteins.

Authors:  M Saijo; M Niikura; S Morikawa; T G Ksiazek; R F Meyer; C J Peters; I Kurane
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  Characterization of Palyam serogroup orbiviruses isolated in South Africa and serologic evidence for their widespread distribution in the country.

Authors:  T Whistler; R Swanepoel; B J Erasmus
Journal:  Epidemiol Infect       Date:  1989-04       Impact factor: 2.451

7.  Ebola protein analyses for the determination of genetic organization.

Authors:  L H Elliott; A Sanchez; B P Holloway; M P Kiley; J B McCormick
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Hemolytic-uremic syndrome--an outbreak in Sacramento, California.

Authors:  M F Rogers; L D Budnick; I Kirson; E S Hurwitz; M H Hatch; C A Bopp; M A Karmali; G W Gary; R Layne; L B Schonberger
Journal:  West J Med       Date:  1986-02

9.  Risk factors for Marburg hemorrhagic fever, Democratic Republic of the Congo.

Authors:  Daniel G Bausch; Matthias Borchert; Thomas Grein; Cathy Roth; Robert Swanepoel; Modeste L Libande; Antoine Talarmin; Eric Bertherat; Jean-Jacques Muyembe-Tamfum; Ben Tugume; Robert Colebunders; Kader M Kondé; Patricia Pirad; Loku L Olinda; Guénaël R Rodier; Patricia Campbell; Oyewale Tomori; Thomas G Ksiazek; Pierre E Rollin
Journal:  Emerg Infect Dis       Date:  2003-12       Impact factor: 6.883

10.  Production of monoclonal antibodies and development of an antigen capture ELISA directed against the envelope glycoprotein GP of Ebola virus.

Authors:  Andreas Lucht; Roland Grunow; Christian Otterbein; Peggy Möller; Heinz Feldmann; Stephan Becker
Journal:  Med Microbiol Immunol       Date:  2003-10-31       Impact factor: 4.148
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.